Integrated Analysis of Pre-Marketing Safety Data, Statistical Considerations and Estimands (part I) presented by Dr. Katarina Hedman, AstraZeneca
2:45 PM
Break
3:00 PM
Integrated Analysis of Pre-Marketing Safety Data, Statistical Considerations and Estimands (part II) presented by Dr. George Kordzakhia, AstraZeneca
7:00 PM
Banquet Dinner